IGHG1 and glioblastoma: We also found that patients with a high expression of IGHG1 had shorter PFI in TCGA cohort (LGG: HR = 1.44, 95%CI = 1.09–1.89, p = 0.009; GBM: HR = 1.41, 95%CI = 1.00–1.99, p = 0.053) (Supplementary Figures S1A–D).